Part,  Chapter, Paragraph

 1    I,     2.  2       |            period 1997 to 2004 and 26% in the opposite direction.
 2    I,     2.  7       |           Brazil has approximately 26 million inhabitants, yet
 3    I,     3.  1       |         with levels between 24 and 26 years of age.~ ~Closer inspection
 4    I,     3.  1       |     Republic (2.85) and Romania (2.26). Cohorts born in the 1930s
 5    I,     3.  1       |             at ages between 24 and 26. Only in younger cohorts
 6    I,     3.  3       |           9), followed by Germany (26.8), Sweden (26.4) and Belgium (
 7    I,     3.  3       |            Germany (26.8), Sweden (26.4) and Belgium (26.1). In
 8    I,     3.  3       |         Sweden (26.4) and Belgium (26.1). In this group of countries
 9    I,     3.  3       |            recent value amounts to 26.8 for 2004, which corresponds
10   II,     5.  2.  7   |    mortality from heart disease in 26 countries from 1950 to 1978.
11   II,     5.  3.  5   |        Southern Europe (Figure 5.3.26) reflects the PSA test diffusion.
12   II,     5.  3.  5   |       standard) in 2006~Figure 5.3.26. Trends of prostate cancer (
13   II,     5.  4.  3   |    reported by EUCID range between 26/1000 (Finland) and 76/1000 (
14   II,     5.  4.  8   |            Diabetes Care. 2003 Apr;26(4):1270-6.~Greenfield S,
15   II,     5.  5.  1   |   projected lifetime prevalence 13-26% in the participating EU
16   II,     5.  5.  3   |           Denmark, 34% in Hungary, 26% in Germany, 23% in France,
17   II,     5.  5.  3   |            generalized seizures in 26-32%, and unclassifiable
18   II,     5.  5.  3   |           Acta Neurol Scand 103:20-26~Pugliatti M, Sotgiu S, Rosati
19   II,     5.  5.  3   |      multiple sclerosis. Neurology 26:20-22.~Rothwell PM, Charlton
20   II,     5.  5.  3   |        range from 5 per 100,000 to 26 per 100,000, according to
21   II,     5.  5.  3   |           s disease. J Chronic Dis 26(4):243-254.~Späte HF, Gemende
22   II,     5.  6.  6   |            Norway. Scand J Soc Med 26:34-43~Brooks PM (1997):
23   II,     5.  7.  1   |          entails a cost excess of $26.000 per case per year in
24   II,     5.  7.  7   |             Semin Nephrol 2006 Jan;26(1):68-79.~Kurella M, Lo
25   II,     5.  7.  7   |        Epidemiol 2007 Jan;17(1):19-26.~Lysaght MJ (2002) Maintenance
26   II,     5.  8.  3   |            higher was estimated at 26.1%, regardless of gender,
27   II,     5.  8.  6   |       receive long-term home care (26% vs 9.7%, p<0.05), but were
28   II,     5.  9.  3   |           three years, from 24% to 26% in the age group 15 years
29   II,     5. 10.  5   |          as SO2 .~ ~Directive 2005/26/EC~- Lupin and products
30   II,     5. 10.  5   |          Commission Directive 2005/26/EC establishing a list of
31   II,     5. 10.  7   |          Commission Directive 2005/26/EC of 21 March 2005 establishing
32   II,     5. 12.  7   |       consumption. Int J Epidemiol 26:100-109.~ ~Corrao G, Aricò
33   II,     6.  3.  3   |         diagnoses were reported by 26 countries. Previous trends
34   II,     6.  3.  3   |          cases reported in 2005 by 26 countries, the highest incidence
35   II,     6.  3.  4   |    resulted in 8 098 SARS cases in 26 countries, with 774 deaths.
36   II,     6.  3.  5   |         494 cases were reported by 26 countries. Ireland (with
37   II,     6.  3.  5   |        were reported by Ireland (2.26) and Germany (0.94). Elimination
38   II,     6.  3.  6   | paratyphoid cases were reported by 26 countries. Norway, with
39   II,     6.  3.  6   | shigellosis cases were reported by 26 countries. The European
40   II,     6.  3.  6   |         per 100 000) and the UK (9.26 per 100 000) reporting the
41   II,     6.  3.  7   |     malaria cases were reported by 26 countries (France not reporting).
42   II,     8.  1.  5(7)|        Fundamental Rights, Article 26: "The Union recognises and
43   II,     8.  2.  2   |         earlier resolution (WHA 56.26) and created a global mandate
44   II,     8.  2.  3   |   prevalence of slight impairment (26-40dBHL) has been estimated,
45   II,     9.  1.  1   |            varies per country from 26 per 1 000 live births (Lithuania)
46   II,     9.  1.  1   |           Biol Reprod (Paris) 1997;26(4):358-66.~ ~Langhoff-Roos
47   II,     9.  2.  7   |          commitments.pdf (accessed 26.11.06)~ ~European Commission (
48   II,     9.  3.  1   |         for women and men, about 1.26 million hip fractures occur
49   II,     9.  3.  2   |         act, the ratio declined to 26 per 100 000 in 2002-2004,
50   II,     9.  3.  2   |        babies born alive at 25 and 26 weeks of gestation now have
51   II,     9.  3.  2   |           Biol Reprod (Paris) 1997;26(4):358-66.~ ~Langhoff-Roos
52   II,     9.  3.  3   |             Annu Rev Public Health 26:319-39.~Haavio-Mannila E,
53   II,     9.  4.  3   |        self harm are approximately 26% higher in Europeans over
54   II,     9.  4.  7   |         disease?Diabetes Care 2003;26:688-696.~ ~EPHA briefing
55   II,     9.  5.  3   |           last 5 years~Lithuania26.5% of women reported sexual
56   II,     9.  5.  3   |            16 year-olds found that 26% of boys and 22% of girls
57   II,     9.  5.  4   |      harmful use of alcohol (WHA58.26[53]) of 2005, which recognizes
58   II,     9.  5.  4   |          cancer (WHA Resolution 60.26 Workers' Health: Global
59  III,    10.  1.  3   |      effects. Med Sci Sports Exerc 26(7):838-843. ~ ~
60  III,    10.  2.  1   |         and Experimental Research, 26, 478-484.~ ~Kunst AE, Groenhof
61  III,    10.  2.  1   |         and by bicycle declined by 26% and 24% between 1975/1976
62  III,    10.  2.  1   |            in Sports and Exercise, 26:857-865.~ ~Popkin B M, Duffey
63  III,    10.  2.  1   |        obesity ranged from 7.4% to 26.6% among men and between
64  III,    10.  2.  1   |           men and between 8.9% and 26.0% among women.~ ~Figure
65  III,    10.  2.  1   |            Journal of Epidemiology 26:860866.~ ~Branca F, Nikogosian
66  III,    10.  2.  1   |   REGULATION (EC): No 1182/2007 of 26 September 2007 laying down
67  III,    10.  2.  1   |        Related Metabolic Disorders 26:1610-1616.~ ~Savva SC, Kourides
68  III,    10.  2.  1   |        Related Metabolic Disorders 26:1036-1045.~ ~Savva SC, Tornaritis
69  III,    10.  3.  1   |         the WHO recommendations in 26 countries. Policies and
70  III,    10.  4.  2   |  Particularly, Chapter V (articles 26 through 34) considers the
71  III,    10.  4.  2   |     European Communities No. L 404/26, 30 December 2006. Available
72  III,    10.  4.  5   |      disposal or recovery.~· EC of 26 April 1999 on the landfill
73  III,    10.  4.  5   |            Directive 1999/31/EC of 26 April 1999 on the landfill
74  III,    10.  5.  1   |           research and technology, 26(4): 285-300~ ~Zhao Z, Sebastian
75  III,    10.  5.  3   |          latter convention by only 26 countries (ILO, 2007). Among
76  III,    10.  5.  3   |      reduction in medical costs of 26%, the return-on-investment
77  III,    10.  6.  2   |         states (www ). Bodies from 26 countries will analyse and
78   IV,    11.  2.  1   |            Belgium (28%), Ireland (26%) and Croatia (17%) (HFA
79   IV,    11.  3.  2   |            as in Belgium, fixed at 26% lower) (Mrazek and Mossialos,
80   IV,    11.  5.  4   |           of Europe’s Agreement No 26 on the exchange of therapeutic
81   IV,    11.  6.  2   |        Germany and Luxembourg, to €26-65 in Finland, Ireland (
82   IV,    11.  6.  4   |       Health. Sickness Fund Scheme~26 competitive sickness funds~
83   IV,    11.  6.  5   |         Medical Errors." Retrieved 26 June, 2006, from http://
84   IV,    11.  6.  5   |          Annals of Pharmacotherapy 26: 422-8.~ ~Taxis K, Barber
85   IV,    12.  4       |          2013)~Council Decision of 26 June 1990 on expenditure
86   IV,    12. 10       |        environment Grenelle24-25-26 October 2007:~htt e5~Adoption
87   IV,    12. 10       |        environment Grenelle24-25-26 October 2007:~htt ~ Plan
88   IV,    12. 10       |      transposition of UE directive 26/03/02 about air traffic:~htt ~
89   IV,    13.  7.  2   |       noticeably higher in the US (26.8%) than in the EU (18.4%)